Which ETFs own 009420.KS?
Hanall Biopharma Co Ltd — 11 ETFs hold it, worth $35.5M across 952.75K shares.
Holdings as of Aug 26, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | EEMS iShares MSCI Emerging Markets Small-Cap… | 0.09% | 7.36K | $330.9K | $372.4M | Emerging Markets | +0.49% | |
| 2 | SCHC Schwab International Small-Cap Equity… | 0.05% | 64.57K | $2.8M | $5.79B | Developed Markets | -0.48% | |
| 3 | VSS Vanguard FTSE All-World ex-US Small-Cap… | 0.02% | 115.31K | $3.4M | $13.60B | Developed Markets | -0.11% | |
| 4 | TLTE Northern Trust Morningstar Emerging… | 0.01% | 1.13K | $45.9K | $353.5M | Emerging Markets | +0.02% | |
| 5 | IEMG iShares Core MSCI Emerging Markets ETF | 0.01% | 372.92K | $16.3M | $160.58B | Emerging Markets | -0.05% | |
| 6 | VPL Vanguard FTSE Pacific ETF | 0.01% | 32.13K | $956.6K | $13.10B | Developed Markets | -0.49% | |
| 7 | DFSE Dimensional Emerging Markets… | 0.01% | 855 | $37.4K | $642.2M | Emerging Markets | +0.03% | |
| 8 | DFAE Dimensional - Emerging Core Equity… | 0.00% | 9.10K | $398.4K | $10.02B | Emerging Markets | 0.00% | |
| 9 | IXUS iShares Core MSCI Total International… | 0.00% | 55.28K | $2.4M | $61.10B | Developed Markets | -0.40% | |
| 10 | VEA Vanguard FTSE Developed Markets ETF | 0.00% | 288.38K | $8.6M | $315.00B | Developed Markets | -0.46% | |
| 11 | VSGX Vanguard ESG International Stock ETF | 0.00% | 5.71K | $170.0K | $6.50B | Developed Markets | -0.25% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.